急性心筋梗塞症

出版社： 永井書店
著者：
発行日： 2005-09-01
分野： 臨床医学：内科  >  心臓
ISBN： 4815917272
電子書籍版： 2005-09-01 （第1版）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

7,150 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

3,575 円(税込)

購入する

商品紹介

近年、急性心筋梗塞症の知慮成績が、冠動脈再灌流療法、とくにカテーテルによる冠動脈形成法primary PCIの導入により、めざましい進展を見せています。本書は、このような時期に、急性心筋梗塞症の病態、診断、治療の現状につき解説を試みたものです。

目次

  • 急性心筋梗塞症

    ―目次―

    第1章　急性心筋梗塞症の基礎
    第2章　臨床症状・所見
    第3章　検査所見
    第4章　救急治療
    第5章　合併症
    第6章　不整脈
    第7章　再灌流治療
    第8章　ST上昇を伴わない心筋梗塞
    第9章　薬物療法
    第10章　退院・社会復帰

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 急性心筋梗塞症の基礎

P.30 掲載の参考文献
1) National Heart , Lung, and Blood Institute , Morbidity and Mortality Chart Book : National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, 2000.
 
2) Swan HJC, Forrester JS, Diamond GA, et al : Hemodynamic spectrum of myocardial infarction and cardiogenic shock. A conceptual model. Circulation 1972 ; 45 : 1097-1110.
 
3) Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI) : Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986 ; 1 : 397-401.
PubMed
4) The GUSTO Investigators : An intemational randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993 ; 329 : 673-682.
 
5) Fibrinolytic Therapy Trials (FTT) Collaborative Group : Indications for fibrinolytic therapy in suspected acute myocardial infarction : Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1,000 patients. Lancet 1994 ; 343 : 311-322.
 
6) Weaver WD, Simes RJ, Betriu A, et al : Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review. JAMA 1997 ; 278 : 2093-2098.
PubMed
7) Grines CL, Cox DA, Stone GW, et al, for Stent Primary Angioplasty in Myocardial Infarction Study Group : Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999 ; 341 : 1949-1956.
PubMed
8) Stone GW, Grines CL, Cox DA, et al, for the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complication (CADILAC) Investigators : Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002 ; 346 : 957-966.
PubMed
9) Kizer JR, Cannon CP, McCabe CH, et al : Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice. Am Heart J 1999 ; 137 : 79-92.
PubMed
10) Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care : International consensus on science. Circulation 2000 ; 102 : 1-1-1-384.
 
11) Ross R : The pathogenesis of atherosclerosis : A perspective of the 1990s. Nature 1993 ; 362 : 801-809.
PubMed
12) Corti R, Fuster v, Badimon JJ : Pathogenic concepts of acute coronary syndromes. J Am Coll Cardiol 2003 ; 41 : 7S-14S.
 
13) Galis Z, Sukhova G, Kranzhofer R, et al : Macropharge foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci USA 1995 ; 92 : 402-406.
 
14) Yeghiazarians Y, Braunstein JB, Askari A, et al : Unstable angina pectoris. N Engl J Med 2000 ; 342 : 101-114.
PubMed
15) Libby P : Molecular bases of the acute coronary syndromes. Circulation 1995 ; 91 : 2844-2850.
PubMed
16) Shah P : Mechanisms of plaque vulnerability and rupture. J Am Coll Cardiol 2003 ; 41 : 15S-22S.
PubMed
17) Aikawa M, Libby P : Lipid lowering reduces proteolytic and prothrombotic potential in rabbit atheroma. Ann New York Acad Sci 2000 ; 902 : 140-152.
 
18) Aikawa M, Rabkin E, Sugiyama S, et al : An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation 2001 ; 103 : 276-283.
PubMed
19) Lee RT, Grodzinsky AJ, Frank EH, et al : Stnlcture dependent dynamic mechanical behavior of fibrous caps from human atherosclerotic plaques. Circulation 1991 ; 83 : 1764-1770.
PubMed
20) van der Wal AC, Becker AE, van der Loos CM, et al : Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994 ; 89 : 36-44.
PubMed
21) Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999 ; 340. 115-126.
PubMed
22) Rioufol G, Finet G, Ginon I, et al : Multiple atherosclcrotic plaque rupture in acute coronary syndrome. A three-vessel intravascular ultrasound study. Circulation 2002 ; 106 : 804-808.
PubMed
23) Ehara S, Ueda M, Naruko T, et al : Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001 ; 103 : 1955-1960.
PubMed
24) Tsitrios S, Berkmark C, Beyer RW, et al : Temporal increase in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J Am Coll Cardiol 2003 ; 41 : 360-370.
 
25) Liuzzo G, Biasucci LM, Gallimore JR, et al : The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994 ; 331 : 417-424.
PubMed
26) Ridker PM : Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003 ; 107 : 363-369.
PubMed
27) Tomoda H, Aoki N : Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction. Am Heart J 2000 ; 140 : 324-328.
PubMed
28) Fernandeds-Ortiz A, Badim on JJ, Falk E, et al : Characterization of the relative thrombogenecity of atherosclerotic plaque components : Implications for consequences of plaque rupture. J Am Coll Cardiol 1994 ; 23 : 1562-1569.
 
29) Rosenber RD, Aird WC : Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999 ; 340 : 1555-1564.
 
30) Annex BH, Denning SM, Channon KM, et al : Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995 ; 91 : 619-622.
PubMed
31) Fuster V : Mechanisms leading to myocardial infarction : Insights from studies of vascular biology. Circulation 1994 ; 90 : 2126-2146.
PubMed
32) Tomoda H, Aoki N : Clinical evaluation of coronary lesion characteristics in acute myocardial infarction. Angiology 2003 ; 54 : 277-285.
PubMed
33) Tomoda H : Development of an experimental model of acute myocardial infarction and the effects of athromboxane synthetase inhibitor (OKY-046). Am Heart J 1986 ; 112 : 698-704.
 
34) Tomoda H : Experimental study on myocardial salvage by coronary thrombolysis and mechanical recanalization. Am Heart J 1988 ; 116 : 687-695.
 
35) Monchada S, Vane JR : Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med 1979 ; 300 : 1142.
 
36) ISIS-2 (Second International Study of Infarct Survival) Collaborative Group : Randomized trial of intravenous streptokinase, oral aspirin , both or neither among 17,187 cases of suspected acute myocardial infarction. ISIS-2. Lancet 1988 ; 2 : 349-360.
PubMed
37) Tomoda H : Experimental evaluation of coronary thrombodynamics and effects of pharmacological intervention in acute coronary syndromes. Jap Circul J 1992 ; 56 : 1184-1190.
 
38) Montalescot G, Barragan P, Wittenberg O, et al, for ADMIRAL Investgators : Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001 ; 344 : 1895-1903.
PubMed
39) The GUSTO Angiographic Investigators : The comparative effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993 ; 329 : 1615-1622.
PubMed
40) Boersma E, Maas ACP, Deckers JW, et al : Early thrombolytic treatment in acute myocardial infarction ; reappraisal of the golden hour. Lancet 1996 ; 348 : 771-775.
 
41) Tomoda H : Electrocardiographic prediction of the success of coronary reperfusion by intravenous thrombolytic therapy : An experimental study. Angiology 1992 ; 43 : 631-640.
PubMed
42) Neely JR, Morgan HE : Reladonship between carbohydrate and lipid metabolism and energy balance of the heart. Ann Rev Physiol 1974 ; 36 : 413-459.
 
43) Jennings RB, Reimer KA, Hill ML, et al : Total ischemia in dog hearts, in vivo ; 1. Comparison of high energy phosphate production, utilization, and depletion, and of adenosine nucleotide catabolism in total ischemia in vitro vs. severe ischemia in vivo. Circ Res 1981 ; 49 : 892-900.
 
44) Opie LH : Myocardial ischemia-metabolic pathway and implications of increased glycolysis. Cardiovasc Drug Ther 1990 ; 4 : 777-790.
 
45) Reimer KA, Jennings RB, Hill ML : Total ischemia in dog hearts, in vitro ; 2. High energy phosphate depletion and associated defects in energy metabolism, cell volume regulation and sarcolemmal integrity. Circ Res 1981 ; 49 : 901-911.
PubMed
46) King LM, Opie LH : Glucose and glycogen utilization in myocardial ischemia-Changes in metabolism and consequences for the myocyte. Moll Cell Biochem 1988 ; 180 : 3-26.
 
47) Opie LH : Pathophysiolosy and biochemistry of ischemia, necrosis, and reperfusion. In Acute myocardial infarction. Gersh BJ, Rahimtoola SH, ed. Chapman & Hall, New York, 1997, p51-67.
 
48) Vagas SO, Sampson BA, Schoen FJ : Pathologic detection of early myocardial infarction : A critical review of the evolution and usefulness of modem techniques. Mod Pathol 1999 ; 12 : 635-645.
 
49) Kim C, Braunwald E : Potential benefits of late reperfusion of infarcted myocardium : The open artery hypothesis. Circulation 1993 ; 88 : 2426-2434.
PubMed
50) Heyndrickx GR, Millard RW, McRitchie RJ, et al : Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 1975 ; 56 : 978-985.
 
51) DeBoer LW, Ingwall JS, Moner RA, et al : Prolonged derangements of canine myocardial purine metabolism after a brief coronary occlusion not associated with anatomic evidence of necrosis. Proc Natl Acad Sci USA 1980 ; 77 : 5471-5475.
 
52) Steenbergen C, Murphy E, Levy L, et al : Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat heart. Circ Res 1987 ; 60 : 700-707.
PubMed
53) Bolli R, Jeroudi MO, Patel BS, et al : Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion : Evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res 1989 ; 65 : 607-622.
PubMed
54) Bolli R, Triana JF, Jeroudi MO : Prolonged impairment of coronary vasodilatation after reversible ischemia ; Evidence for microvascular stunning. Circ Res 1990 ; 67 : 332-343.
PubMed
55) Kloner RA, Bolli R, Marban E, et al : Medical and cellular implications of stunning. hibernation, and preconditioning : An NHLBI workshop. Circulation 1998 ; 97 : 1848-1867.
PubMed
56) Marzilli M, Orsini E, Marraccini P, et al : Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000 : 101 : 2154-2159.
PubMed
57) Kloner RA : Does reperfusion injury exist in humans? J Am Coll Cardiol 1993 ; 21 : 537-545.
PubMed
58) Dreyer WL, Michael LH, Wist S, et al : Neutrophil accumulatioon in ischemic canine myocardium. Insights into time course, distribution and mechanisms of localization during early reperfusion. Circulation 1991 ; 84 : 400-411.
 
59) Tomoda H, Aoki N : Right bundle branch block in acute myocardial infarction treated by primary coronary angioplasty. Circulation 2002 ; 106 : II-532.
 
60) Grines CL, Serruys P, O'Neill WW : Fibrinolytic therapy. Is it a treatment of the past? Circulation 2003 ; 107 : 2538-2542.
PubMed
61) Keeley EC, Boura JA, Grines CL : Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction ; A quantitative review of 23 randomised trials. Lancet 2003 ; 361 : 13-20.
PubMed
62) Pfeffer MA : Left ventricular remodeling after acute myocardial infarction. Ann Rev Med 1995 : 46 : 455-466.
PubMed
63) Pfeffer MA, Braunwald E : Ventricular remodeling after myocardial infarction : Experimental observations and clinical implications. Circulation 1990 ; 81 : 1161-1172.
PubMed
64) Jugdutt BI : Ventricular remodeling after infarction and the extracellular collagen matrix. What is enough enough? Circulation 2003 ; 108 : 1395-1403.
PubMed
65) Hirayama A, Adachi T. Asada S, et al : Late reperfUsion fOr acute myocardial infarction limits the dilatation of left ventricle without reduction of infarct size. Circulation 1993 ; 88 : 2565-2574.
PubMed
66) Mury CE, Jennings RB, Reimer KA : Preconditioning with ischemia : A delay of lethal cell injury in ischemic myocardium. Circulation 1986 ; 74 : 1124-1136.
 
67) Kuzuya T. Hoshida S, Yamashita N, et al : Delayed effects of sublethal ishchemia on the acquisition of tolerance to ischemia. Cir Res 1993 ; 72 : 1293-1299.
 
68) Ishihara M, Sato H, Tateishi H, et al : Implications of prodromal angina pectoris in anterior wall acute myocardial infarction : Acute angiographic findings and long-term prognosis. J Am Coll Cardiol 1997 ; 30 : 970-975.
PubMed
69) Tomoda H, Aoki N : Comparison of protective effects of preinfarction angina pectoris in acute myocardial infarction treated by thrombolysis versus by primary coronary angioplasty with stenting. Am J Cardiol 1999 ; 84 : 621-625.
PubMed
70) Tomoda H, Aoki N : Coronary blood flow in evolving myocardial infarction preceded by preinfarction angina ; a critical reevaluation of preconditioning effects in clinical cases. Angiology 2004 ; 55 : 9-15.
PubMed
71) Tomoda H, Aoki N : Pathophysiology of early coronary angioplasty with stenting on non-Q-wave vs. Q-wave myocardial infarction. Angiology 2001 ; 52 : 671-679.
PubMed

第2章 臨床症状・所見

P.41 掲載の参考文献
1) Canto JG, Shlipak MG, Rogers WG, et al : National Registry of Myocardial Infarction. Prevalence, clinical characteristics , and mortality among patlents with myocardial infarction presenting without chest pain. JAMA 2000 : 283 : 3223-3229.
 
2) Kannel WB, Abott RD : Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham Study. N Engl J Med 1984 ; 311 : 1144-1147.
 
3) Goldberg R, Goff D. Cooper L, et al : Age and sex differences in presentation of symptoms among patients with acute coronary disease. Coronary Artery Dis 2000 ; 11 : 399-407.
PubMed
4) Pasceri V, Ciaflone D, Finociaro ML, et al : Relation between myocardia infarction site and pain location in Q-wave acute myocardial infarction. Am J Cardiol 1995 ; 75 : 224-227.
 
5) Dell'Italia IJ, Starling MR, O'Rourke RA : Physical examination for exclusion of hemodynamically important right ventricular infarction. Ann Intern Med 1984 ; 101 : 797-798.
 
6) Killip T, Kimball JT : Treatment of myocardial infarction in a coronary care unit : A two year experience with 250 patients. Am J Cardiol 1967 ; 20 : 457-464.
 

第3章 検査所見

P.76 掲載の参考文献
1) Bar FW, Volders PG, Hoppener P, et al : Development of ST-segment elevation and Q-and R-wave changes in acute myocardial infarction and the influence of thrombolytic therapy. Am J Cardiol 1996 ; 77 : 337-343.
 
2) Mauri F, Gasparini M, Barbonaglia L, et al : Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI trial). Am J Cardiol 1989 ; 63 : 1291-1295.
PubMed
3) Birnbaum Y, Sclarovsky S, Solodky A, et al : Prediction of the level of left anterior descending coronary artery obstruction during anterior wall acute myocardial infarction by the admission electro-cardiogram. Am J Cardiol 1993 ; 72 : 823-826.
 
4) Yamaji H, Iwasaki K, Kusachi S, et al : Prediction of acute left main coronary artery obstruction by 12-lead electrocardiography. ST segment elevation in lead aVR with less ST segment elevation in lead V1. J Am Coll Cardiol 2001 ; 38 : 1348-1354.
PubMed
5) Klein HO, Tordijman T, Ninio R, et al : The early recognition of right ventricular infarction : Diagnostic accuracy of the elctrocardiographic V4R lead. Circulation 1983 ; 67 : 558-565.
 
6) Gibson RS, Crampton RS, Watson DD, et al : Precordial ST-segment depression during acute inferior myocardial infarction : Clinical , scintigraphic and angiographic correlations. Circulation 1982 ; 66 : 732-741.
PubMed
7) Parikh A, Shah PK : New insight into the electrocardiogram of acute myocardial infarction. I Acute myocardial infarction. In Gersh BJ, Rahimtoola SH (ed), Acute myocardial infarction. 2nd ed, Chapman & Hall, 1996. p163-188.
 
8) Bairey CN, Shah PK, Lew AS, et al : Electrocardiographic differentiation of occlusion of the left circumflex vs. right coronary arterirs as a cause of inferior acute myocardial infarction. Am J Cardiol 1987 ; 60 : 456-459.
 
9) Menown IBA, Adgey AAJ : Improving the ECG classification of inferior and lateral myocardial infarction by inversion of lead aVR. Heart 2000 ; 83 : 657-660.
 
10) Lazar EJ, Goldberger J, Peled H, et al : Atrial infarction ; Diagnosis and managernent. Am Heart J 1988 ; 116 : 1058-1002.
PubMed
11) Hains DE, Raabe DS, Gundel WD, et al : Anatomic and prognostic significance of new T-wave inversion in unstable angina. Am J Cardiol 1983 ; 52 : 14-18.
 
12) Sgarbossa EB, Pinski SL, Barbagelata A, et al : Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle branch block. GUSTO-1 Investigators, N Engl J Med 1996 ; 334 : 481-487.
 
13) Shah PK, Cercek B, Lew A, et al : Angiographic validation of bed side markers of reperfusion. J Am Coll Cardiol 1993 ; 21 : 55-61.
 
14) Tomoda H : Electrocardiographic prediction of the success of coronary reperfusion by intravenous thrombotic therapy ; An experimental study. Angiology 1992 ; 43 : 631-640.
 
15) Poli A, Fetiveau R, Vandoni P, et al : Integrated analysis of myocardial blush and ST-segment elevadon recovery after successful primary angioplasty. Real-time grading of microvascular reperfusion and prediction of early and late recovery of left ventricular function. Circulation 2002 ; 106 : 313-318.
PubMed
16) Feldman IJ, Coste P, Furber A, et al : Incomplete Resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction after stenting for acute myocardial infarction. Circulation 2003 ; 107 : 2684-2689.
 
17) Gorgels APM, Vos MA, Letsch IS, et al : Usefulness of accelerated idioventricular rhythm as a marker for myocardial necrosis and reperfusion during thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1988 ; 61 : 231-235.
 
18) Esente P, Giambartolomei A, Gensini G, et al : Coronary reperfusion and Bezold-Jarisch reflex (bradycardia and hypotension). Am J Cardiol 1983 ; 52 : 221-224.
PubMed
19) The joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000 ; 36 : 959-969.
 
20) Ohman EM, Armstrong PW, Christenson RH, et al : Cardiac troponin T fOr risk stratification in acute myocardial ischemia. N Engl J Med 1996 ; 335 : 1333-1341.
PubMed
21) Lindhal B, Venge P, Wallentin L, et al : Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. J Am Coll Cardiol 1997 ; 29 : 43-48.
 
22) Heeschen C, Hamm CW, Goldmann B, et al : Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efflcacy of tirofiban. Lancet 1999 ; 354 : 1757-1762.
PubMed
23) Kaul P, Newby K, Fu Y, et al. Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients. J Am Coll Cardiol 2003 ; 41 : 371-380.
 
24) Schiller NB, Shah PM, Crawford M, et al : Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiography 1989 ; 2 : 358-367.
PubMed
25) Bourdillon PDV, Broderick TM, Sawada SG, et al : Regional wall motion index for infarct and noninfarct regions after acute myocardial infarction : Comprison with global wall motion index. J Am Soc Echo 1989 ; 2 : 398-407.
 
26) Gibson RS, Bishop HL, Stamm RB, et al : Value of early two dimensional echocardiography in patients with acute myocardial infarction. Am J Cardiol 1982 ; 49 : 1110-1119.
PubMed
27) Oh JK, Gibbons RI, Christian TF, et al : Correlation of regional wall motion abnomalities detected by two-dimensional echocardiography with perfusion defect determined by technetium-99m sestamibi imaging in patients treated with reperfusion therapy during acute myocardial infarction. Am Heart J 1996 ; 131 : 32-37.
 
28) Sabia P, Afrookteh A, Touchstone DA, et al : Value of regional wall motion abnormality in the emergency room diagnosis of acute myocardial infarction : A prospective study using two-dimensional echocardiography. Circulation 1991 : 84 (Suppl I) : 85-92.
 
29) Libemlan AN, Weiss JL, Jugdutt BI, et al : Two-dimensional echocardiography and infarct size : Relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog. Circulation 1981 ; 63 : 739-746.
 
30) St. John Sutton M, Heffer MA, Plappert J, et al : Quantitative two dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circuladon 1994 ; 89 : 68-75.
 
31) Cerisano G, Bolognese L, Carrabba N, et al : Doppler-derived mitral deceleration time : An early strong predictor of left ventricular remodeling after reperfused anterior acute myocardial infarction. Circulation 1999 ; 99 : 230-236.
PubMed
32) Miyatake K, Okamoto M, Kinoshita N, et al : Doppler echocardiographic features of ventricular septal rupture in myocardial infarction. J Am Coll Cardiol 1985 ; 5 : 182-187.
PubMed
33) Deshmukh HG, Kohsla S, Jefferson KK : Direct visualization of left ventricular free wall rupture by transesophageal echocardiography in acute myocardial infarction. Am Heart J 1993 ; 126 : 475-477.
 
34) Lopez-Sendon J, Gonzalez A, de sa Lopez E, et al. Diagnosis of subacute ventricular wall rupture after acute myocardial infarction : Sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria. J Am Coll Cardiol 1992 ; 19 : 1145-1153.
 
35) Oh JK, Seward JB, Khandheria BK, et al : Transesophageal echocardiography in critically ill patients. Am J Cardiol 1990 ; 66 : 1492-1495.
PubMed
36) Minz GS, Victor MF, Kotler MN, et al : Two-dimensional echocardiogarphic identification of surgically correctable complication of acute myocardial infarction. Circulation 1981 ; 64 : 91-96.
 
37) Jugdutt BI, Sussex BA, Sivaram CA, et al : Right ventricular infarction : Two-dimensional echocardiogarphic evaluation. Am Heart J 1984 ; 107 : 505-518.
 
38) Bowers TR, σNeill WW, Grines CL, et al : Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med 1998 ; 338 : 933-940.
 
39) Lopez-Sendon J, Garcia-Fernandez MA, Coma-Canella I, et al : Segmental right ventricular function after acute myocardial infarction : Two-dimensional echocardiographic study in 63 patients. Am J Cardiol 1983 ; 51 : 390-396.
PubMed
40) Asinger RW, Mikell FL, Elsperger J, et al : Incidence of left ventricular thrombus after acute myocardial infarction : Serial evaluation by two-dimensional echocardiography. N Engl J Med 1981 ; 305 : 297-302.
PubMed
41) Delemarre BJ, Visser CA, Bot H, et al : Prediction of apical thrombus formation in acute myocardial infarction based on left ventricular spatial flow pattern. J Am Coll Cardiol 1990 ; 15 : 355-360.
PubMed
42) Nihoyannopoulos P, Smith GC, Maseri A, et al : The natural history of left ventricular thrombus in myocardial infarction : A rationale in support of masterly inactivity. Am J Cardiol 1989 ; 14 : 903-911.
 
43) Bansal RC, Pai RG, Hauck AJ, et al : Biventricular apical mpture and formation of pseudoaneurysm : Unique flow patterns by Doppler and color flow imaging. Am Heart J 1992 ; 124 : 497-500.
PubMed
44) Sutherland GR, Smyllie JH : Croelandt JRT. Advantages of colour且ow imaging in the diagnosis of left ventricular pseudoaneurysm. Br Heart J 1989 ; 61 : 59-64.
 
45) Smart SC, Sawada S, Ryan T, et al : Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993 ; 88 : 405-415.
PubMed
46) Pellikka PA, Roger VL, Oh JK, et al : Stress echocardiography. Part II. Dobutamine stress echocardiography : Techniques, implementation, clinical applications, and correlations. Mayo Clin Proc 1995 ; 70 : 16-27.
PubMed
47) Carlos ME, Smart SC, Wynsen JC, et al : Dobutamine stress echocardiography for risk stratification after myocardial infarction. Circulation 1997 ; 95 : 1402-1410.
PubMed
48) Picano E, Sicari R, Landi P, et al : Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after uncomplicated myocardial infarction : A dobutamine stress echocardiographic study. Circulation 1998 ; 98 : 1078-1084.
PubMed
49) Smart SC, Knickelbine T, Stoiber TR, et al : Safety and accuracy of dobutamine-atropine stress echocardiography for the detection of residual stenosis of the infarct-related artery and multivessel disease during the first week after acute myocardial infarction. Circulation 1997 ; 95 : 1394-1401.
PubMed
50) Ito H, Tomooka T, Sakai N, et al : Lack of myocardial perfusion immediately after successful thrombolysis : A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992 ; 85 : 1699-1705.
PubMed
51) Hodgson JM, Reddy KG, Suneja R, et al : Intracoronary ultrasound imaging : Correlation of plaque morphology with angiography, clinical syndrome and procedural results in patients undergoing coronary angioplasty. J Am Coll Cardiol 1993 ; 21 : 35-44.
PubMed
52) Nissen SE : Clinical images from intravascular ultrasound : Coronary disease, plaque rupture, and intervention-the inside view. Am J Cardiol 2001 ; 88 (8A) : 16K-18K.
PubMed
53) Yamagishi M, Terashima M, Awano K, et al : Morphology of vulnerable coronary plaque ; Insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndromes. J Am Coll Cardiol 2000 ; 35 : 106-111.
PubMed
54) Tanaka A, Kawarabayashi T, Taguchi H, et al : Use of preintervention intravascular ultrasound in patients with acute myocardial infarction. Am J Cardiol 2002 ; 89 : 257-261.
PubMed
55) Miller TD, Christian TF, Hopfenspirger MR, et al : Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation 1995 ; 92 : 334-341.
PubMed
56) Morimoto K, Tomoda H, Yoshitake M, et al : Prediction of coronary artery lesions in unstable angina by iodine 123 beta-methyl iodophenyl pentadecanoic acid (BMIPP), afatty acid analogue, single photon computed tomography. Angiology 1999 ; 50 : 639-648.
 
57) Tomoda H, Yoshioka K, Shiina Y, et al : Regional sympathetic denervation detected by iodine 123 metaiodobenzylguanidine in non-Q-wave myocardial infarction and unstable angina. Aln Heart J 1994 ; 128 : 452-458.
 
58) Tamaki N, Kawamoto M, Tadamura E, et al : Prediction of reversible ischemia after revascularization. Circulation 1995 ; 91 : 1697-1705.
PubMed
59) Tomoda H : Evaluation of intracardiac thrombus with computed tomography. Am J Cardiol 1983 ; 51 : 843-852.
PubMed
60) Kwong RY, Schussheim AE, Rekhraj S, et al : Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation 2003 ; 107 : 531-537.
PubMed
61) Wu E, Judd RM, Vargas JD, et al : Visualization of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001 ; 357 : 21-28.
PubMed
62) Wagner A, Mahrholdt H, Holly TA, et al : Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfUsion imagig for detection of subendocardial myocardial infarcts : An imaging study. Lancet 2003 : 361 : 374-379.
 
63) Ueda Y, Asakura M, Hirayama A. et al : Intracoronary morphology of culprit lesions after reperfusion in acute myocardial infarction : Serial angioscopic observations. J Am Coll Cardiol 1996 ; 27 : 606-610.
PubMed
64) Mizuno K, Satomura K, Miyamoto A, et al : Angioscopic evaluation of coronary artery thrombi in acute coronary syndromes. N Engl J Med 1992 ; 326 : 287-291.
PubMed
65) Parmley WW, Diamond G, Tomoda H, et al : Clinical evaluation of left ventricular pressures in myocardial infarction. Circulation 1972 ; XLV : 358-366.
 
19a) Braunwald E, Antman EM, Beasley JW, et al : ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction : Executive summary and recommendations. Circulation 2000 ; 102 : 1193-1200.
 

第4章 救急治療

P.92 掲載の参考文献
1) Standards and guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiac care (ECC). JAMA 1986 ; 255 : 2905-2922.
PubMed
2) Guidelines 2000 for cardiopulmanary resuscitation and emergency cardiovascular care. An international consensus on science. Circulation 2000 ; 102 (Suppl) : 1-1-1-384,
 
3) AHA : The automated external defibrillator. Key link in the chain of survival. Circulation 2000 ; 102 : 1-60-1-76.
 
4) Wik L, Hansen TB, Fylling F, et al : Delaying defibrillation to give basic cardiopulmonary resuscitation to patients with out-of-hospital ventricular fibrillation. A randomized trial. JAMA 2003 ; 289 : 1389-1395.
PubMed
5) Cannon CP, Hand MH, Bahr R, et al : National Heart Attack Alert Program (NHAAP) Coordinating Committee Critical Pathways Writing Group. Critical pathways for management of patients with acute coronary syndromes : An assessment by the National Heart Attack Alert Program. Am Heart J 2002 ; 143 : 777-789.
PubMed

第5章 合併症

P.115 掲載の参考文献
1) Killip T. Kimball JT : Treatment of myocardial infarction in a coronary care unit : A two year experience with 250 patients. Aln J Cardiol 1967 ; 20 : 457-464.
 
2) Forrester JS, Diamond G, Swan HJC : Correlative classification of clinical and hemodynamic function after acute myocardial infarction. Am J Cardiol 1977 ; 39 : 137-145.
 
3) Yusuf S, Wittes J, Freidman L : Overview of results of randomized clinical trials in heart disease I : Treatments following myocardial infarction. JAMA 1988 ; 260 : 2088-2093.
 
4) Tuttle RR : Dobutamine. Development of a new catecholamine to electively increase cardiac contractility. Circ Res 1975 ; 36 : 185-196.
 
5) Tomoda H : Experimental study on the extracorporeal ultrafiltration method in advanced heart failure. Tokai J Exp Clin Med. 1988 ; 27 : 5-11.
 
6) Wu AH, Parson L, Every NR, et al : Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction. A report from the second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 2002 ; 40 : 1389-1394.
 
7) Swan HJC : Power failure in acute myocardial infarction. Prog Cardiovasc Dis 1970 ; 12 : 568-580.
 
8) Antman EM, Braunwald E : Acute myocardial infarction. In Braunwald E, Fauci A, Kasper D, et al : Harrison, s Principles of Internal Medicine. 15th 2d. New York, NY : McGraw-Hill ; 2001 : 1395.
 
9) Sleeper LA, Buller CE, et al : lmplications of the timing of onset of cardiogenic shock after acute myocardial infarction : A report from the SHOCK Trial Registry. Should we emergently revascularize Occluded Coronaries for Cardiogenic shocK? J Am Coll Cardiol 2000 ; 36 : 1084-1090.
PubMed
10) Hochman JS : Cardiogenic shock complicating acute myocardial infarction. Expanding the paradigm. Circulation 2003 ; 107 : 2998-3002.
PubMed
11) Goldberger RJ, Gore JM, Thompson CA. et al : Recent magnitude and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction ; The second national registry of myocardial infarction. Am Heart J 2001 ; 141 : 65-72.
 
12) Goldberg R, Gore J, Alpert J, et al : Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community wide perspective, 1975-1988. N Engl J Med 1991 ; 325 : 1117-1122.
PubMed
13) Hands ME, Rutherford JD, Muller JE, et al : The in-hospital development of cardiogenic shock after myocardial infarction : Incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group. J Am Coll Cardiol 1989 ; 14 : 40-46.
 
14) Wong SC, Sanborn T, Sleeper LA, et al : Angiographic findings and clinical correlates in patients with cardiogenic shock complicating acute myocardial infarction : Areport from the SHOCK Trial Registry. Should we emergently revascularize Occluded Coronaries in shocK? J Am Coll Cardiol 2000 ; 36 : 1077-1083.
 
15) Hochman JS, Buller CE, Sleeper LA, et al : Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome : A report from the SHOCK Trial Registry. Should we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000 ; 36 : 1063-1070.
PubMed
16) Webb JG, Sleeper LA, Buller CE, et al : Implications of the timing of onset of cardiogenic shock after acute myocardial infarction : A report from the SHOCK Trial Registry. Should we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000 ; 36 : 1084-1090.
PubMed
17) Hochman JS, Boland J, Sleeper LA, et al, and the SHOCK Registry Investigators : Current spec trum of cardiogenic shock and effect of early revascularization on mortality : Results of an international registry. Circulation 1995 ; 91 : 873-881.
 
18) Holmes DR Jr, Berger PB, Hochman JS, et al : Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 1999 ; 100 : 2067-2073.
PubMed
19) Haley JH, Sinak LJ, Tajik AJ, et al : Dynamic left ventricular outflow tract obstruction in acute coronary syndromes : An important cause of new murmur and cardiogenic shock. Mayo Clin Proc 1999 ; 74 : 901-906.
PubMed
20) Sanborn TA, Sleeper LA, Bates ER, et al : Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction ; A report from the SHOCK Trial Registry. Should we emergently revascularize Occluded Coronaries for carddiogenic shock? J Am Coll Cardiol 2000 ; 36 : 1123-1129.
 
21) Barron HV, Every NR, Parsons LS, et al : The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction : Data from the National Registry of Myocardial Infarction 2. Am Heart J 2001 ; 141 : 933-939.
 
22) Stone GW, Ohman EM, Miller MF, et al : Contemporary utilization and outcome of intra-aortic balloon counterpulsation in acute myocardial infarction. J Am Coll Cardiol 2003 ; 41 : 1940-1945.
PubMed
23) Jaski BE, Lingle RI, Overlie P, et al : Long-term survival with use of percutaneous extracorpo real life support in patients presenting with acute myocardial infarction and cardiovascular collapse. ASAIO J 1999 ; 45 : 615-618.
 
24) Shawl F, Domanski M, Hernandez T, et al : Emergency percutaneous cardiopulmonary bypass support in cardiogenic shock from acute myocardial infarction. Am J Cardiol 1989 ; 64 : 967-980.
PubMed
25) Hochman JS, Sleeper LA, Webb JG, et al : Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize Occluded Coronaries for cardiogenic Shock. N Engl J Med 1999 ; 341 : 625-634.
PubMed
26) Webb JG, Sanborn TA, Sleeper LA, et al : Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial registry. Am Heart J 2001 ; 141 : 964-970.
PubMed
27) Hochman JS, Sleeper LA, White HD, et al : One-year survival following early revascularization for cardiogenic shock. JAMA 2001 ; 285 : 190-192.
PubMed
28) Holmes DR Jr, Bates ER, Kleiman NS, et al : Contemporary reperfusion therapy for cardiogenic shock : The GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 1995 ; 26 : 668-674.
PubMed
29) Edep ME, Brown DL : Effect of early revascularization on mortality from cardiogenic shock cornplicating acute myocardial infarction in California. Am J Cardiol 2000 ; 85 : 1185-1188.
PubMed
30) Marso SP, Steg G, Plokker T, et al : Catheter-based reperfusion of left main stenosis during an acute myocardial infarction (the ULTIMA experience). Am J Cardiol 1999 ; 83 : 1513-1517.
PubMed
31) Bowers TR, O'Neill WW, Grines CL, et al : Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med 1998 ; 338 : 933-940.
 
32) Isner JM, Roberts WC : Right ventricular infarction complicating left ventricular infarction secondary to coronary artery disease. Am J Cardiol 1978 ; 42 : 885-894.
 
33) Sharkey SW, Shelly W, Carlyle PF, et al : M-mode and two-dimensional echocardiographic analysis of the septum in experimental right ventricular infarction : Correlation with hemodynamic alterations. Am Heart J 1985 ; 110 : 1210-1218.
 
34) Lopez-Sendon J, Coma-Canella I, Gammallo C : Sensitivity and specificity of hemodynamic criteria in the diagnosis of acute right ventricular infarction. Circulation 1981 ; 64 : 515-525.
 
35) Lloyd EA, Gersh BJ, Kennelly BM : Hemodynamic spectrum of dominant right ventricular infarction in 19 patients. Am J Cardiol 1981 ; 48 : 1016-1022.
 
36) Goldstein JA, Tweddell JS, Barzilai B, et al : Importance of left ventricular function and systolic ventricular interaction to right ventricular performance during acute right heart ischemia. J Am Coll Cardiol 1992 ; 19 : 704-711.
 
37) Cintron GB, Hernandez E, Linares E, et al : Bedside recognition , incidence and clinical course of right ventricular infarction. Am J Cardiol 1981 ; 47 : 224-224.
PubMed
38) Dell, Italia IJ, Starling MR, O, Rourke RA : Physical examination for exclusion of hemodynamically important right ventricular infarction. Ann Intern Med 1983 ; 99 : 608-611.
 
39) Klein HO, Tordjman T, Ninio R, et al : The early recognition of right ventricular infarction : Diagnostic accuracy of the electrocardiographic V4R lead. Circulation 1983 ; 67 : 558-565.
PubMed
40) Zehender M, Kasper W, Kauder E, et al : Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med 1993 ; 328 : 981-988.
PubMed
41) Wellens HJJ : The value of the right precordial leads of the electrocardiogram. N Engl J Med 1999 ; 340 : 381-383.
 
42) Lopez-Sendon J, Garcia-Fernandez MA, Coma-Canella I, et al : Segmental right ventricular function after acute myocardial infarction : Two-dimensional echocardiographic study in 63 patients. Am J Cardiol 1983 ; 51 : 390-396.
PubMed
43) Jugdatt BI, Sussex BA, Sivaram CA, et al : Right ventricular infarction : Two-dimensional echocardiographic evaluation. Am Heart J 1984 ; 107 : 505-518.
 
44) Zehender M, Kasper W, Kauder E, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med 1993 ; 328 : 981-988.
PubMed
45) Asano H, Sone T, Tsuboi H, et al. Diagnosis of right ventricular infarction by overlap images of simultaneous dual emission computed tomography using technetium-99m pyrophosphate and thallium-201. Am J Cardiol 1993 ; 71 : 902-908.
PubMed
46) Dell, Italia IJ, Lembo NJ, Starling MR, et al : Hemodynamically important right ventricular infarction : Follow-up evaluation of right ventricular systolic function at rest and during exercise with radionuclide ventriculography and aspirated gas exchange. Circulation 1987 ; 75 : 996-1003.
 
47) Reeder GS : Identification and treatment of complications of myocardial infarction. Lancet 1995 ; 70 : 880-884.
 
48) Reddy SG, Roberts WC : Frequency of rupture of the left ventricular free wall or ventricular septum among necropsy cases of fatal acute myocardial infarction since introduction of coronary care units. Am J Cardiol 1989 ; 63 : 906-911.
PubMed
49) Honnan MB, Harrell FE, Remer KA, et al : Cardiac rupture , mortality, and the timing of thrombolytic therapy : Ameta-analysis. J Am Coll Cardiol 1990 ; 16 : 359-367.
 
50) Gertz SD, Kragel AH, Kalan JM, et al : Comparison of coronary and myocardial morphologic findings in patiellts with and without thrombolytic therapy during fatal first acute myocardial infarction. The TIMI Investigators. Am J Cardiol 1990 ; 66 : 904-909.
PubMed
51) Bulkley BH, Roberts WC : Steroid therapy during acute myocardial infarction : A cause of delayed healing and of ventricular aneurysm. Am J Med 1974 ; 56 : 244-250.
PubMed
52) Oliva PB, Hammil Sc, Edwards WD : Cardiac rupture, a clinically predictable complication of acute myocardial infarction : Report of 70 cases with clinicopathological correlations. J Am Coll Cardiol 1993 ; 22 : 720-726.
 
53) Pifarre R, Sullivan HJ, Grieco J, et al : Management of left ventricular rupture complicating myocardial infarction. J Thorac Cardiovascular Surg 1983 ; 86 : 441-443.
PubMed
54) Padro JM, Mesa JM, Silvestra J, et al : Subacute cardiac rupture : Repair with a sutureless technique. Ann Thorac Surg 1993 ; 55 : 20-23.
 
55) March KL, Sawada SG, Tarver RD, et al : Current concept of left ventricular pseudoaneurysm : Pathophysiology, therapy, and diagnsotic imaging methods. Clin Cardiol 1989 ; 12 : 531-40.
 
56) Bansal RC, Pai RG, Hauck AI, et al : Biventricular apical rupture and formation of pseudoaneurysm : Unique flow patterns by Doppler and color flow imaging. Am Heart J 1992 ; 497-500.
 
57) Crenshaw BS, Granger CB, Bimbaum Y, et al : Risk factors, angiographic patterns and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. Circulation 2000 ; 101 : 27-32.
 
58) Edwards B S, Edwards WD, Edwards JE. Ventricular septal rupture complicating acute myocardial infarction : Identification of simple and complex types in 53 autopsied hearts. 1984 ; 54 : 1201-1205.
PubMed
59) Mann JM, Roberts WC : Acquired ventricular septal defect during acute myocardial infarction : Analysis of 38 unoperated necropsy patients and comparison with 50 unoperated necropsy patients without rupture. Am J Cardiol 1988 ; 62 : 8-19.
PubMed
60) Held AC, Cole PL, Lipton B, et al : Rupture of the interventricular septum complicating acute myocardial infarction : A multicenter analysis of clinical findings and outcome. Am Heart J 1988 ; 116 : 1330-1336.
PubMed
61) Radford MJ, Johnson RA, Daggett WM, et al : Ventricular septal rupture : A review of clinical and physiologic features and an analysis of survival. Circulation 1981 ; 64 : 545-553.
 
62) Moore CA, Nygaad TW, Kaiser DL, et al : Postinfarction ventricular rupture : The importance of location of infarction and right ventricular function in determining survival. Circulation 1986 ; 74 : 45-55.
 
63) Miyatake K, Okamoto M, Kinoshita N : Doppler echocardiographic features of ventricular septal rupture in myocardial infarction. J Am Coll Cardiol 1985 ; 5 : 182-187.
PubMed
64) Lemery R, Smith HC, Gersh BJ, et al : Prognosis in rupture of the left ventricular septum after myocardial infarction. Role of early surgical intervention. Am J Cardiol 1992 ; 70 : 147-151.
 
65) Cummings RG, Reimer KA, Califf R, et al : Quantitative analysis of right and left ventricular infarction in the presence of postinfarction ventricular septal defect. Circulation 1988 ; 77 : 33-42.
PubMed
66) Skillington PD, Davies RH, Luff AJ, et al : Surgical treatment for infarct-related ventricular septal defects : Improved early results combined with analysis of late fUnctional status. J Thorac Cardiovasc Surg 1990 ; 99 : 798-808.
PubMed
67) Barbour DJ, Roberts WC : Rupture of LV papillary muscle during acute myocardial infarction : Analysis of 22 necropsy patients. J Am Coll Cardiol 1986 ; 8 : 558-565.
 
68) Nishimura RA, Schaff HV, Shub C, et al : Papillary muscle rupture complicating acute myocardial infarction : Analysis of 17 patients. Am J Cardiol 1983 ; 51 : 373-377.
PubMed
69) Seward JB, Khandheiria BK, Oh JK, et al : Transesophageal echocardiography technique, anatomic correlations, implimentation, and clinical applications. Mayo Clin Proc 1988 ; 63 : 649-680.
 
70) Kishon Y, Oh JK, Schaff HV, et al : Mitral valve operation in post infarction rupture of a papillary muscle : Immediate results and long-term follow-up of 22 patients. Mayo Clin Proc 1992 ; 67 : 1023-1030.
 

第6章 不整脈

P.136 掲載の参考文献
1) Pantridge JF, Geddes JS : Primary ventricular fibrillation. Eur J Cardiol 1974 ; 1 : 335-337.
PubMed
2) Kinoshita E, Tomoda H, Hamamoto H, et al : An experimental study on isochronal ventricular mapping in acute myocardial infarction. Tokai J Exp Clin Med 1988 ; 13 : 109-119.
 
3) Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. International consensus on science. Circulation 2000 ; 102 : I-1-I-384.
 
4) Lown B, Eolf M : Approaches to sudden death from coronary heart disease. Circulation 1971 ; 44 : 130-142.
 
5) Cannon DS, Prystowsky EN : Management of ventricular arrhythmias : Detection, drugs, and devices. JAMA 1999 ; 281 : 171-179.
 
6) Campbell RWF, Murray A, Julian DG : Ventricular arrhythmia in first 12 hours of acute myocardial infarction : Natural history study. Br Heart J 1981 ; 46 : 351-357.
 
7) Gressin V, Gorgels A, Louvard Y, et al : ST-segment normalization time and ventricular arrhythmias as electrocardiographic markers of reperfusion duhng intravenous thrombolysis for acute myocardial infarction. Am J Cardiol 1993 ; 15 : 1436-1439.
 
8) Nicod P, Gilpin E, Dittrich H, et al : Late clinical outcome in patients with early ventricular fibrillation after myocardial infarction. J Am Coll Cardiol 1988 ; 11 : 464-470.
PubMed
9) Antman EM, Berlin JA : Declining incidence of ventricular fibrillation in myocardial infarction. Circulation 1992 ; 86 : 764-773.
PubMed
10) Harris AS : Delayed development of ventricular ectopic rhythms following experimental coronary occlusion. Circulation 1950 ; 1 : 1318-1329.
PubMed
11) Newby KH, Thompson T, Stebbins A, et al : Sustained ventricular arrhythmias in patients receiving thrombolytic therapy. Incidence and outcome. Circulation 1998 ; 98 : 2567-2573.
PubMed
12) Pfeffer MA, Braunwald E, Moye LA on behalf of the SAVE investigators : Effect of Captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992 ; 327 : 669-677.
 
13) Moss AJ, Davis HJ, DeCamilla J, et al : Ventricular ectopic beats and their relation to sudden and nonsudden cardiac deaths after myocardial infarction. Circulation 1979 ; 60 : 998-1003.
 
14) Bigger JT, Fleiss JL, Kleiger R, et al : The relationship among ventricular arrhythmias, left ventricular dysfunction and mortality 2 years after myocardial infarction. Circulation 1984 ; 69 : 250-258.
PubMed
15) Maggioni AP, Zuanetti G, Franzosi MG, et al : Prevalence and prognosdc significance of ventricular arrhythmia after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation 1993 ; 87 : 312-322.
PubMed
16) McClements BM, Adgey AAJ : Value of signal-averaged electrocardiography, radionuclide ventriculography, Holter monitoring and clinical variables for prediction of arrhythmic events in survivors of acute myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1993 ; 21 : 1419-1427.
 
17) Zoni-Berisso M, Molini D, Mela GS, et al : Value of programmed ventricular stimulation in predicting sudden death and sustained ventricular tachycardia in survivors of acute myocardial infarction. Am J Cardiol 1996 ; 77 : 673-680.
PubMed
18) Pedretti R, Etro MD, Laporta A, et al : Prediction of late arrhythmic events after acute myocardial infarction from combined use on noninvasive prognostic variables and inducibility of sustained mono-morphic ventdcular tachycardia. Am J Cardiol 1993 ; 71 : 1131-1141.
 
19) Huikuri H, Tapanainen JM, Lindgren K, et al : Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2003 ; 42 : 652-658.
PubMed
20) Woods KL, et al : Intravenous magnesium sulphate in suspected acute myocardial infarction : Results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1992 ; 339 : 1553-1558.
PubMed
21) Tan HL, Lie KI : Prophylactic lidocaine use in acute myocardial infarction revisited in the throm-bolytic era. Am Heart J 1999 ; 137 : 770-773.
 
22) MacMahorn S, et al : Effect of prophylactic lidocaine in suspected acute myocardial infarction. J Am Coll Cardiol 1988 ; 13 : 1910-1916.
 
23) Teo KK, Yusurf CD, Furberg CD : Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. JAMA 1993 ; 270 : 1589-1595.
 
24) Epstein AE, Hallstrom AP, Rogers WJ, et al : Mortality following ventricular arrhythmia suppression by encainide , flecainide, and moricizine after myocardial infarction : The original design concept of the Cardiac Arrhythmia Supression Trial (CAST). JAMA 1993 ; 270 : 2451-2455.
 
25) Moss AJ, Hall WJ, Cannon DS, et al : Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996 ; 335 : 1933-1940.
 
26) Moss AJ, Zareba W, Hall WJ, et al : Prophylactic implantation of a defibrillator in patients with myocardial infarction, and reduced ejection fraction. N Engl J Med 2002 ; 346 : 877-883.
PubMed
27) Scheinman MM, Gonzalez RP : Fascicular block and acute myocardial infarction. JAMA 1980 ; 244 : 2646-2649.
PubMed
28) Harpaz D, Behar S, Gottlieb S, et al : Complete atrioventricular block complicating acute myocardial infarction in the thrombolytic era. J Am Coll Cardiol 1999 ; 34 : 1721-1728.
PubMed
29) Zoll PM, Zoll RH, Falk RH, et al : External noninvasive temporary cardiac pacing : Clinical trials. Circulation 1985 ; 71 : 937.
PubMed
30) Edlar M, Canetti M, Rotstein Z, et al : Significance of paroxysmal atrial fibrillation complicating acute myocardial infarction in the thrombolytic era. Circulation 1998 ; 97 : 965-970.
 
31) Waldo AL, Camm AJ, deRuyter H, et al : Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 1996 ; 348 : 7-12.
 
32) Cairns JA, Connoly SJ, Roberts R, et al : Randomized trial of outcome after myocardial infarction in patients with frequent and repetitive ventricular premature depolarizations : CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 1997 ; 349 : 675-682.
 
33) Julian DG, Camm AJ, Frangin G, et al : Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardia infarction : EMAT. Lancet 1997 ; I at 349 : 667-674.
 
34) Burkart F, Pfisterter M, Kiowski W, et al : Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias : Basel antiarrhythmic study of infarct survival (BASIS). J Am Coll Cardiol 1990 ; 16 : 1711-1718.
 

第7章 再灌流療法

P.167 掲載の参考文献
1) Rogers WJ, Canto JG, Lambrew CT, et al : Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999 : The National Registry of Myocardial Infarction 1, 2and 3. J Am Coll Cardiol 2000 ; 36 : 2056-2063.
 
2) Keeley EC, Boura JA, Grines CL : Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review of 23 randomised trials. Lancet 2003 ; 361 : 13-20.
PubMed
3) G rines CL, Serruys P O 'Neill WW : Fibrinolytic therapy. Is it a treatment of the past? Circulation 2003 ; 107 : 2538-2542.
 
4) Rentrop KP, Blanke H, Karsch KR : Acute myocardial infarction : Intracoronary application of nitroglycerin and streptokinase in combination with transluminal recanalization. Clin Cardiol 1979 ; 2 : 354-363.
 
5) Van de Verf : The ideal fibrinolytic : Can drug design improve clinical results? Eur Heart J 1999 ; 20 : 1452-1458.
 
6) Brener SJ, Topol EJ : Third-generation thrombolytic agents for acute myocardial infarction. In : Topol E (ed), Acute coronary syndromes. Marcel Dekker Inc, New York, 1998 ; p. 169.
 
7) GUSTO Investigators : An increased randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993 ; 329 : 673-682.
 
8) Llevadot J, Giugliano RP, Antman EM : Bolus fibrinolytic therapy in acute myocardial infarction. JAMA 2001 ; 286 : 442-449.
PubMed
9) Kawai C, Yui Y, Hosoda S, et al for the E6010 Study Group : A prospective randomized, double blind multicenter trial of a single-bolus injection of the novel modified t-PA E6010 in the treat-ment of acute myocardial infarction : Comparison with native t-PA. J Am Coll Cardil 1997 ; 29 : 1447-1453.
 
10) Cannon CP, McCabe CH, Driver DJ, et al : Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction : Results of the Thrombolysis in Myocardial Infarction-TIMI 4 trial. J Am Coll Cardiol 1994 ; 24 : 1602-1610.
 
11) Assessment of the Safety and Efficacy of a New Thrombolytic Investigators : Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction : The ASSENT-2 double-blind randornized trial. Lancet 1999 ; 354 : 716-722.
PubMed
12) Topol E, Califf R, Ohman E, et al : A comparison of reteplase with alteplase for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. N Engl J Med 1997 ; 337 : 1118-1123.
 
13) den Heijer P, Vermeer F, Ambrosioni F, et al : Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction : A double-blind , randomized angiographic trial of lanoteplase versus alteplase. Circulation 1998 ; 98 : 2117-2125.
 
14) Hampton J, Wilcox R, Armstrong P, et al : LATE Study Group. Late assessment thrombolytic efficacy study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993 ; 342 : 759-766.
 
15) Fibrinolytic Therapy Trialists' (FTT) Collaborative Group : Indications for fibrinolysis therapy in suspected acute myocardial infarction : Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1, 000 patients. Lancet 1994 ; 343 : 311-322.
 
16) Newby LK, Rutsch W, Califf RM, et al : Time from symptom onset to treatment and outcomes after thrombolysis therapy. J Am Coll Cardiol 1996 ; 27 : 1646-1655.
PubMed
17) National Heart Attack Alert Coordinating Committee , 60 Minutes to Treatment Working Group : mergency department : Rapid identification and treatment of patients with acute myocardial infarction. Ann Emerg Med 1994 ; 23 : 311-329.
 
18) Cannon CP : Critical pathway for management of patients with acute coronary syndromes. An assessment by the National Heart Attack Alert Program. Am Heart J 2002 ; 143 : 777-789.
PubMed
19) The European Myocardial Infarction Project Group : Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction, N Engl J Med 1993 ; 329 : 383-389.
PubMed
20) Rawles J : Halving of mortality at 1 year by domiciliary thrombosis in the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol 1994 ; 23 : 1-5.
 
21) Morrison IJ, Verbeek PR, McDonald AC, et al : Mortality and prehospital throlnbolysis for acute myocardial infarction : Ameta-analysis. JAMA 2000 ; 283 : 2686-2692.
 
22) Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care. International consensus on science. Circulation 2000 ; 102 : 1-1-1-384.
 
23) Canto JG, Rogers WJ, Bowlby U, et al : National Registry of Myocardial Infarction 2 Investigators. The pre-hospital electrocardiogram in acute myocardial infarction : Is its full potential being recognized? J Am Coll Cardiol 1997 ; 29 : 498-505.
 
24) Armstrong PW, Collen D, Antman E : Fibrinolysis for acute myocardial infarction. The future is here and now. Circulation 2003 ; 107 : 2533-2537.
PubMed
25) Thiemann DR, Coresh J, Schulman SP, et al : Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 yr. Circulation 2000 ; 101 : 2239-2246.
 
26) Bottiger BW, Bode C, Kern S, et al : Eficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation : A prospective clinical study. Lancet 2001 ; 357 : 1583-1585.
 
27) Simoons ML, Maggionl AP, Knatterud G, et al : Individual risk assessment for intracranial hemorrhage during thrombolytic therapy. Lancet 1993 ; 342 : 1523-1528.
 
28) Gruppo Italiano per lo Studio della Streptochinasi nell'lnfarto Miocardico (GISSI) : Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986 ; 1 : 397-402.
PubMed
29) ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randolnized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction ; ISIS-2. Lancet 1988 ; 2 : 349-360.
PubMed
30) Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico GISSI-2 : A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990 ; 336:65-71.
PubMed
31) Morrow DA, Antman EM, Charlesworth A, et al : TIMI risk score for ST-elevation myocardial infarction : A convenient, bedside, clinical score for risk assessment at presentation. An In TIME II study. Circulation 2000 ; 102 : 2031-2037.
 
32) TIMI Study Group : Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985 ; 312 : 932-936.
 
33) Anderson JL, Karagounis LA, Becker LC, et al : TIMI 3 perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction : Ventriculographic, enzymatic, and electrocardiographic evidence from the TEAM-3 study. Circulation 1993 ; 87 : 1829-1839.
PubMed
34) The GUSTO Angiographic Investigators : The comparative effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993 ; 329 : 1615-1622.
PubMed
35) Gibson CM, Cannon CP, Daley WL, et al : TIMI frame count. A quantitative method of assessing coronary artery flow. Circulation 1996 ; 93 : 879-888.
 
36) Gibson CM, Cannon CP, Murphy SA, et al : Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000 ; 101 : 125-130.
PubMed
37) Matetzky S, Freimark D, Chouraqui P, et al : The distinction between coronary and myocardial perfusion after thrombolytic therapy by clinical markers of reperfusion. J Am Coll Cardiol 1998 ; 32 : 1326-1330.
PubMed
38) Gurwitz JH, Gore JM, Goldberg Rl, et al : Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction : Patients in the National Registry of Myocardial Infarction 2. Ann Int Med 1998 ; 129 : 597-604.
 
39) Weaver WD, Simes RJ, Betriu A, et al : Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review. JAMA 1997 ; 278 : 2093-2098.
PubMed
40) Ross AM, Coyne KS, Reiner JS, et al : A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction ; The PACT trial. J Am Coll Cardiol 1999 ; 34 : 1954-1962.
 
41) Antman EM, Giugliano RP, Gibson CM, et al : Abciximab facilitates the rate of thrombolysis. Results of the Thrombolysis In Myocardial Infarction (TIMI) 14 trial. Circulation 1999 ; 99 : 2720-2731.
PubMed
42) The GUSTO V Investigators : Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination of reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition : The GUSTO V randomized trial. Lancet 2001 ; 357 : 1905-1914.
 
43) Giugliano RP, Roe MT, Harrington RA, et al : Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction. Results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) phase II angiographic tria1. J Am Coll Cardiol 2003 ; 41 : 1251-1260.
 
44) The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators : A colnparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996 ; 335 : 775-782.
 
45) HERO 2 Investigators : Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction : The HIRO 2 trial. Lancet 2001 ; 358 : 1855-1863.
 
46) Grines CL, Browne KF, Marco J, et al : A comparison of immediate angioplasty with thrombolytic therapy fOr acute myocardial infarction. N Engl J Med 1993 ; 32 : 673-679.
 
47) Zijlstra F, de Boer JM, Hoorntje JC, et al : A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993 ; 328 : 680-684.
 
48) O'Keefe JH, Bailey WL, Rutherford BD, et al : Primary angioplasty for acute myocardial infarction in 1,000 consecutive patients. Results in an unselected population and high-risk subgroups. Am J Cardiol 1993 ; 72 : 107G-115G.
 
49) The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators : A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. New Engl J Med 1997 ; 336 : 1621-1628.
 
50) Gibbons RI, Holmes DR, Reeder GS, et al : Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment fOr myocardial infarction. N Engl J Med 1993 ; 328 : 685-691.
 
51) DeWood MA : Direct PTCA vs intravenous t-PA in acute myocardial infarction : Results from a prospective randomized trial. In : Proceedings from the Thrombolysis and Interventional Therapy in Acute Myocardial Infarction Symposium VI. Washington, DC. George Washington University, 1990 ; p28-29.
 
52) Ribeiro EE, Silva LA, Carneiro R, et al : Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 1993 ; 22 : 376-380.
PubMed
53) Zijlstra F, Beukema W, Van't Hof A, et al : Randomized comparison of primaly coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol 1997 ; 29 : 908-912.
 
54) PCAT Collaborators Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction : Six-month follow up and analysis of individual patient data from randomized trials. Am Heart J 2003 ; 145 : 47-57.
PubMed
55) Stone GW, Grines CL, Browne KS, et al : Predictors of in-hospital and six months outcomes after acute myocardial infarction in the reperfusion era : the Primary Angioplasty in Myocardial Infarction (PAMI) Trial. J Am Coll Cardiol 1995 ; 370-377.
 
56) Stone GW, Grines CL, Browne KF, et al : Influence of acute myocardial infarction location on inhospital and late outcomes after primary percutaneous coronary angioplasty versus tissue plasminogen activator therapy. Am J Cardiol 1996 ; 78 : 19-25.
 
57) Van de Werf F, Wilcox RG, Barbash GI, et al : In-hospital mortality and clinical course of 2,891 patients with suspected acute myocardial infarction randomized between alteplase and streptokinase with and without heparin. Lancet 1990 ; 336 : 71-75.
 
58) Hochman JS, Sleeper LA, Webb JG, et al : Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999 ; 341 : 625-634.
PubMed
59) Ribichini F, Steffenino G, Dellavalle A, et al : Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST depression : Immediate and long term results of a randomized study. J Am Coll Cardiol 1998 ; 32 : 1687-1694.
PubMed
60) Saito S, Hosokawa G, Kim K, et al : Primary stent implantation in acute myocardial infarction. J Am Coll Cardiol 1996 ; 28 : 74-81.
 
61) Antoniucci D, Santoro GM, Bolognese L, et al : A clinical trial comparing primary stenting of the infarct related artery with optimal primary angioplasty fOr acute myocardial infarction. J Am Coll Cardiol 1998 ; 31 : 1234-1239.
PubMed
62) Maillard L, Hamon M, Khalife K, et al : A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2000 ; 35 : 1729-1736.
PubMed
63) Roderiguez A, Bernardi V, Fernandez M, et al : In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Am J Cardiol 1998 ; 81 : 1286-1291.
 
64) Saito S, Hosokawa G, Tanaka S, et al : Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction : Final results of the primary angioplasty versus stent implantation in acute myocardial infarction (PASTA) trial. Pasta Trial Investigators. Cathet Cardiovasc Intervent 1999 ; 48 : 262-268.
 
65) Suryapranata H, van't Hof AWJ, Hoorntje JCA, et al : Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998 ; 97 : 2502-2505.
 
66) Grines CL, Cox DA, Stone GW, et al, for Stent Primary Angioplasty in Myocardial Infarction Study Group : Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999 ; 341 : 1949-1956.
PubMed
67) Stone GW, Grines CL, Cox DA, et al, for the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complication (CADILAC) Investigators : Comparison of angioplasty with stenting, with or without abciximab , in acute myocardial infarction. N Engl J Med 2002 ; 346 : 957-966.
PubMed
68) Linkoff AM, Topol EJ : Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 1993 ; 87 : 1792-1805.
 
69) The GUSTO Angiographic Investigators : The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993 ; 329 : 15-22.
 
70) Laster SB, O'Keefe JHJ, Gibbons RI, et al : Incidence and importance of Thromolysis in Myocardial Infarction grade 3 flow after primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1996 ; 78 : 623-626.
 
71) Stone GW, O'Neill WW, Jones B, et al : The central unifying concept of TIMI-3 flow after primary PTCA in thrombolytic therapy in acute myocardial infarction. Circulation 1996 ; 94 : 1-515.
 
72) Zijlstra F, Hoorntje JCA, deBoer MJ, et al : Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999 ; 341 : 1413-1419.
 
73) Nakagawa Y, Iwasaki Y, Kimura T, et al : Serial angiographic follow-up after successful direct angioplasty fOr acute myocardial infarction. Am J Cardiol 1996 ; 78 : 980-984.
PubMed
74) White HB, Cross DR, Elliot JM, et al : Long-term prognostic importance of patency of the infarct related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation 1994 ; 89 : 61-67.
 
75) Tomoda H : Experimental study on myocardial salvage by coronary thrombolysis and mechanical recanalization. Am Heart J 1988 ; 116 : 687-695.
 
76) Zahn R, Schiele R, Schneider S, et al : Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR). J Am Coll Cardiol 2000 ; 36 : 2064-2071.
PubMed
77) Saia F, Lemo PA, Lee CH, et al : Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction. A clinical angiographic study. Circulation 2003 ; 108 : 1927-1929.
 
78) Liem AL, van'tHof AW, Hoorntje JC, et al : Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol 1998 ; 32 : 629-633.
 
79) Cannon CP, Gibson CM, Lambrew CT, et al : Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000 ; 283 : 2941-2947.
PubMed
80) Sheiban I, Fragasso G, Rosano GMC, et al : Time course and determinants of left ventricular function recovery after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol 2001 ; 38 : 464-471.
 
81) Canto JG, Every NR, Magid DJ, et al : The volume of primary angioplasty procedures and survival after acute myocardial infarction. N Engl J Med 2000 ; 342 : 1573-1580.
PubMed
82) Magid DJ, Calonge BN, Rumsfeld JS, et al : Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA 2000 ; 284 : 3131-3138.
PubMed
83) Ellis SG, Da Silva ER, Spaulding CM, et al : Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction : Insight from the RESCUE I, RESCUE II, and other contemporary clinical experiences. Am Heart J 2000 ; 139 : 1046-1053.
PubMed
84) Ellis SG, da Silva ER, Heyndrickx G, et al : Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation 1994 ; 90 : 2280-2284.
PubMed
85) Abbottsmith CW, Topol EJ, George BS, et al : Fate of patients with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty. J Am Coll Cardiol 1990 ; 16 : 770-778.
PubMed
86) Scheller B, Hennen B, Hammer B, et al : Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol 2003 ; 42 : 634-41.
PubMed
87) Stone GW, Peterson MA. Lansky AJ, et al : Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 2002 ; 39 : 591-597.
PubMed
88) Nakagawa Y, Matsuo S, Kimura T, et al : Thrombectomy with Angiojet catheter in native coronary arteries for patients with acute or recent myocardial infarction. Am J Cardiol 1999 ; 83 : 994-99.
PubMed
89) vanOmmen VG, Michels RI, Heymen E, et al : Usefulness of the Rescueof catheter to remove fresh thrombus from coronary arteries and bypass grafts in acute myocardial infarction. Am J Cardiol 2001 ; 88 : 306-308.
 
90) Fuster V : Mechanisms leading to myocardial infarction : Insight from studies of vascular biology. Circulation 1994 ; 90 : 2126-2146.
PubMed
91) Kotani J, Nanto S, Mintz GS, et al : Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation 2002 ; 106 : 1672-1677.
 
92) Oesterle SN, Hayase M, Baim DS, et al : An embolizalization containment device. Cathet Cardiovasc Intervent 1999 ; 47 : 243-250.
 
93) Louveyre C, Morice MC, Lefevre T, et al : Arandomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. J Am Coll Cardiol 2002 ; 39 : 15-21.
 
94) Brener SJ, Barr LA, Burchenal JEB, et al : Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation 1998 ; 98 : 734-741.
 
95) Neumann FJ, Blasini R, Schmitt C, et al : Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation 1998 ; 98 : 2695-2701.
PubMed
96) Montalescot G, Barragan P, Wittenberg O, et al, for the ADMIRAL Investigators : Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001 ; 344 : 1895-1903.
PubMed
97) van't Hof AWJ, Niem A, Suryapranate H, et al : Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction ; myocardial blush grade : Zwolle Myocardial Infarction Study Group. Circulation 1998 ; 97 : 2302-2306.
 
98) Henriques JPS, Zijlstra F, van'tHof AWJ, et al : Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 2003 ; 107 : 2115-2119.
 
99) Marzilli M, Orsini E, Marraxxini P, et al : Beneficial effects of intracoronary adenosine as an adjunct t o primary angioplasty in acute myocardial infarction. Circulation 2000 ; 101 : 2154-2159.
 
100) Gacioch GM, Topol EJ : Sudden paradox clinical deterioration during angioplasty of the occluded right coronary artery in acute myocardial infarction. J Am Coll Cardiol 1989 ; 14 : 1202-1209.
PubMed
101) Goldberg RI, McCormick D, Gurwitz JH, et al : Age-related trends in short-and long-term survival after acute myocardial infarction : A 20-year population-based perspective (1975-1995). Am J Cardiol 1998 ; 82 : 1311-1317.
 
102) DeGeare VS, Stone GW, Grines CL, et al : Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percuraneous intervention (A pooled analysis of the Primary Angioplasty in Myocardial Infarction). Am J Cardiol 2000 ; 86 : 30-34.
 
103) Hochman JS, Sleeper LA, White HD, et al : One-year survival following early revascuarization for cardiogenic shock. JAMA 2001 ; 285 : 190-192.
PubMed
104) Hochman JS : Cardiogenic shock complicating acute myocardial infarction. Expanding the paradigm. Circulation 2003 ; 107 : 2998-3002.
PubMed
105) Jacobs AK, Leopold JA, Bates E, et al : Cardiogenic shock caused by right ventricular infarction. Areport from the SHOCK registry. J Am Coll Cardiol 2003 ; 41 : 1273-1279.
 
106) Marso SP, Steg G, Plokker T, et al : Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the ULTIMA experience). Am J Cardiol 1999 ; 83 : 1513-1517.
PubMed
107) Brodie BR, Stuckey TD, Hansen C. et al : Intra-aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol 1999 ; 84 : 18-13.
PubMed
108) Fragmin and Fast Revancularization during Instability in Coronary artery disease (FRISC II) investigators : Invasive compared with non-invasive treatment in unstable coronary-artery disease : FRISC II prospective randomized multicenter study. Lancet 1999 ; 354 : 708-715.
PubMed
109) Barron HV, Bowlby LJ, Breen T, et al : Use of reperfusion therapy for acute myocardial infarction in the United States ; Data from the National Registry of Myocardial Infarction 2. Circulation 1998 ; 97 : 1150-1156.
 
110) Shubrooks SJ Jr, Nesto RW, Leeman D, et al : Urgent coronary bypass surgery for failed percutaneous coronary intervention in the stent era : Is backup still necessary? Am Heart J 2001 ; 142 : 190-196.
PubMed
111) Aversona T, Aversona LT, Passamani E : Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery. JAMA 2002 ; 287 : 1943-1951.
 
112) Grines CL, Westerhausen DR, Grines LL, et al : A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction. The Air Primary Angioplasty in Myocardial Infarction Study. J Am Coll Cardiol 2002 ; 39 : 1713-1719.
PubMed
113) Kocher AA, Schuster MD, Szabolcs MJ, et al : Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Med 2001 ; 7 : 430-436.
PubMed
114) Tomita S, Li RK, Weisel RD, et al : Autologous transplantation of bone marrow cells improves damaged heart fUnction. Circulation 1000 ; 100 ; II-247-II-256.
 
115) Shintani S, Murohara T, Ikeda H, et al : Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001 : 103 : 2776-2779.
PubMed
116) Tomoda H, Aoki N : Bone marrow stimulation and left ventricular function in acute myocardial infarction. Clin Cardiol 2003 ; 26 : 455-457.
PubMed
117) Stauer BE, Brehm M, Zeus T, et al : Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002 ; 106 : 1913-1918.
PubMed
118) Assmus B, Schahinger V, Teupe C, et al : Transplantation of cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002 ; 106 : 3009-3017.
 
15a) Boersma E, Maas AC, Deckers JW, et al : Early thrombolytic treatment in acute myocardial infarction : Reappraisal of the golden hour. Lancet 1996 ; 348 : 771-775.
 
92a) Napodans M, Pasquetto G, Succa S, et al : Intracoronary thrombectomy improves myocardial perfusion in patients undergoing direct angioplasty for acute myocardial infarction. Circulation 2003 ; 42 : 1395-1402.
 

第8章 ST上昇を伴わない心筋梗塞

P.184 掲載の参考文献
1) Spodick DH : Qwave infarction versus S-T infarction ; Nonspecificity of electrocardiographic criteria for differentiating transmural and non-transmural lesions. Am J Cardiol 1983 ; 51 : 913-915.
 
2) DeWood MA, Stifter WF, Simpson CS, et al : Coronary arteriographic findings soon after non-Q wave myocardial infarction. N Engl J Med 1986 ; 315 : 417-423.
PubMed
3) Gibson RS : Non-Q-wave myocardial infarction : Prognosis, changing incidence, and management. In Gersh BJ, Rahimutoola SH (ed), Acute myocardial infarction. 2nd ed, Chapman & Hall, New York, 1996 ; p 403-p433.
 
4) Theroux P, Fuster V : Acute coronary syndromes. Unstable angina and non-Q-wave myocardial infarction. Circulation 1998 ; 97 : 1195-1206.
PubMed
5) Geltman EM, Biello D, Welch MJ, et al : Charactedzation of nontransmural myocardial infarcdon by positron emission tomography. Circulation 1982 ; 65 : 747-755.
PubMed
6) Gibson RS : Clinical, functional and angiographic distinctions between Q wave and non-Q wave myocardial infarction : Evidence of spontaneous reperfusion and implications for intervention trials. Circulation 1987 ; 75 (Suppl V) : V128-V138.
 
7) Schechtman KB, Capone RJ, Kleiger RE, et al : Risk stratification of patients with non-Qwave myocardial infarction. Circulation 1989 ; 80 : 1148-1158.
 
8) Cannon CP, Thompson B, McCabe CH, et al : Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes : An analysis from the Thrombolysis in Myocardial Infarction (TIMI) III trials. Am J Cardiol 1995 ; 75 : 977-981.
PubMed
9) Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care : International consensus on science. Circulation 2000 ; 102 : I-1-I-384.
 
10) The SYMPHONY investigators : Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes : A randomized trial. Lancet 2000 ; 355 : 337-345.
PubMed
11) Cohen M, Adams P, Parry G, et al : Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin. Primary end points from the ATACS trial. Antithrombotic Therapy in Acute Coronary research group. Circulation 1994 ; 89 : 81-88.
 
12) Oler A, Whooley M, Oler J, et al : Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina : A meta-analysis. JAMA 1996 ; 276 : 811-815.
PubMed
13) Cohen M, Demers C, Burfinkel EP, et al : A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997 ; 337 : 447-452.
PubMed
14) Antman EM, McCabe CH, Gurfinkel EP. et al : Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial. Circulation 1999 ; 100 : 1593-1601.
PubMed
15) Yusuf S, Zhao F, Mehta SR, et al : Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001 ; 345 : 494-502.
PubMed
16) Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators : A comparison of aspirin plus tirofiban for unstable angina. N Engl J Med 1998 ; 338 : 1498-1505.
 
17) Bazzino O, Barrero C, Gane L, et al : Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med 1998 ; 338 : 1488-1497.
 
18) Topol E, Califf R, Simoon M, et al : Inhibition of platelet glycoprotein IIb/IIIa with epitifibatide with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Amgina : Receptor Supression Using Integrilin Therapy. N Engl J Med 1998 ; 339 : 436-443.
 
19) Moliterno DJ : International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina. The PARAGON Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute coronary syndromes in a Global Organization Network. Circulation 1998 ; 97 : 2386-2395.
PubMed
20) Simoons ML : Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early revascularization : the GUSTO IV-ACS randomized trial. Lancet 2001 ; 357 : 1915-1924.
PubMed
21) Cho L, Topol EJ, Balog C, et al : Clinical benefit of glycoprotein IIb/IIIa blockade with Abciximab is independent of gender : Pooled analysis from EPIC, Epilog and EPISTENT trials. J Am Coll Cardiol 2000 ; 36 : 381-386.
PubMed
22) TIMI IIIB Investigators : Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction : Results of the TIMI IIIB trial. Circulation 1994 ; 89 : 1545-1556.
 
23) Boden WE, O'Rourke RA, Crawford MH, et al : Outcomes in patients with acute non-Qwave myocardial infarction randomly assigned to an invasive as compared to a conservative management strategy. N Engl J Med 1998 ; 338 : 1785-1792.
 
24) Fragmin and Fast Revascularization during InStability in Coronary artery disease (FRISC II) Investigators : Invasive compared with non-invasive treatment in unstable coronary artery disease : FRISC II prospective randomized multicenter study. Lancet 1999 ; 354 : 708-715.
PubMed
25) Cannon CP, Weintraub WS, Demopoulos LA, et al : Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001 ; 344 : 1879-1887.
PubMed
26) Cannon CP, Turpie AGG : Unstable angina and non-ST-elevation myocardial infarction : Initial antithrombotic therapy and early invasive strategy. Circulation 2003 ; 107 : 2640-2645.
PubMed
27) Goldberg RJ, Gore JM, Gurwitz JH, et al : The impact of age on the incidence and prognosis of myocardial infarction : The Worcester Heart Attack Study. Am Heart J 1989 ; 117 : 543-549.
PubMed
28) DeGeare VS. Stone GW, Grines CL, et al : Angiographic and clinical characteristics associated with increased in-hospital mortality in elderly patients with acute myocardial infarction undergoing percuraneous intervention : A pooled analysis of the Primary Angioplasty in Myocardial Infarction. Am J Cardiol 2000 ; 86 : 30-34.
 
29) Goldberg RJ, McCormick D, Gurwitz JH, et al : Age-related trends in short-and long-term survival after acute myocardial infarction : A 20-year population-based perspective (1975-1995). Am J Cardiol 1998 ; 82 : 1311-1317.
 
30) Thieman DR, Coresh J, Sculman SP, et al : Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation 2000 ; 101 : 2239-2246.
 
31) de Boer MJ, Ottervanger JP, van't Hof AW, et al : Reperfusion therapy in elderly patients with acute myocardial infarction. A randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol 2002 ; 39 : 1723-1728.
PubMed
32) Berger AK, Radford MJ, Wang Y, et al : Thrombolytic therapy in older patients. J Am Coll Cardiol 2000 ; 36 : 366-367.
PubMed
33) White HD : Thrombolysis therapy in the elderly. Lancet 2000 ; 356 : 2028-2030.
 
34) The GUSTO-IInvestigators : An intemational randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993 ; 329 : 673-682.
 
35) Weaver WD, Litwin PE, Martin JS, et al : Effects of age on use of thrombolytic therapy and mortality in acute myocardial infarction : The MITI project group. J Am Coll Cardiol 1991 ; 18 : 657-662.
 
36) Chaitman BR, Thompson B, Wittry MD, et al : The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly : Results from thrombolysis in myocardial infarction phase II pilot study. J Am Coll Cardiol 1989 ; 14 : 1159-1165.
PubMed
37) Simoons ML, Miggioni AP, Knatterud G, et al : Individual risk assessment for intracranial hemorrhage during thrombolytic therapy. Lancet 1993 ; 342 : 1523-1528.
 
38) ISIS-I (First International Study of Infarct Survival) Collaborative Group : Trial of intravenous atenolol among 16, 027 cases of suspected acute myocardial infarction : ISIS-I. Lancet 1986 ; 57-66.
 
39) Herlitz J, Elmfeldt D, Holmberg S, et al : Goteborg Metoprolol Trial. Mortality and causes of death. Am J Cardiol 1984 ; 53 : 9D-14D.
PubMed
40) Montague TJ, Ikuta RM, Wong RY, et al : Comparison of risk and pattems of practice in patients older and younger than 70 years with acute myocardial infarction in a two year period (1987-1989). Am J Cardiol 1991 ; 68 : 843-847.
 

第9章 薬物療法

P.206 掲載の参考文献
1) Jugdutt BI, Wamica JW : Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications : Effect of timing, dosage, and infarct location. Circulation 1988 ; 78 : 906-919.
 
2) Yusuf S, Collins R, MacMahon S, et al : Effect of intravenous nitrates on mortality in acute myocardial infarction : An overview of the randomized trials. Lancet 1988 ; 1 : 1088-1092.
PubMed
3) Gruppo Italiano perlo Studio della Soprawivenza nell'Infarto Miocardico ; GISSI-3 : Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6 week mortality and ventricular function after acute myocardial infarction. Lancet 1994 ; 343 : 1115-1122.
 
4) ISIS-4 : A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995 ; 345 : 669-685.
PubMed
5) Furberg CD, Psaty BM, Mayer JV : Nifedipine : Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995 ; 92 : 1326-1331.
 
6) The Multicenter Diltiazem Postinfarction Trial Research Group : The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988 ; 319 : 385-392.
 
7) The Danish study group on verapamil in myocardial infarction : Effect of verapamil on mortality and malor events after acute myocardial infarction (the Danish Verapamil Infarction Trial II-DAVIT II). Am J Cardiol 1990 ; 66 : 779-785.
 
8) Boden WE, Van Gilst WH, Scheldewaert RG, et al : Diltiazem in acute myocardial infarction treated with thrombolytic agents : A randomized placebo-controlled trial. Imcomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT). Lancet 2000 ; 355 : 1751-1756.
 
9) Ito H, Taniyama Y, Iwakura K, et al : Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol 1999 ; 33 : 654-660.
PubMed
10) Marzilli M, Orsini E, Marraccini P, et al : Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000 ; 101 : 2154-2159.
PubMed
11) McAlpine HM, Morton JJ, Leckie B, et al : Neuroendocrine activation after acute myocardial infarction. Br Heart J 1988 ; 60 : 117-124.
PubMed
12) Vaughan DE, Lamas GA, Pfeffer MA, et al : Role of left ventricular dysfunction in selective neurohumoral activation in the recovery phase of anterior wall acute myocardial inねrction. Am J Cardiol 1990 ; 66 : 529-533.
 
13) Rouleau JL, Packer M, Moye L, et al : Prognostic value of neurohumoral activation in patients with acute myocardial infarction : Effect of captopril. J Am Coll Cardiol 1994 ; 24 : 583-591.
PubMed
14) Pfeffer MA, Pfeffer JM : Ventricular enlargement and reduced survival after myocardial infarction. Circulation 1987 ; 75 : W93-97.
 
15) Vaughan DE, Lazos SA, Tong K : Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. J Clin Invest 1995 ; 95 : 995-1001.
PubMed
16) Pfeffer MA, Braunwald E, Moye LA, et al : Effects of captopril on moratlity and lnorbidity in patients with left ventricular dysfunction after myocardial infarction : Result of the survival and ventricular enlargement trial. N Engl J Med 1992 ; 327 : 669-677.
 
17) Swedberg K, Held P, Kiekshus J, et al : Effects of early administration of eranapril on mortality in patients with acute myocardial infarction : Results of the Cooperative New Scandinavian Survival Study II. N Engl J Med 1992 ; 327 : 678-684.
 
18) Sigurdsson A, Swedberg K : Left ventricular remodeling, neurohormonal activation and early treatment with enarapril (CONSENSUS II) following myocardial infarction. Eur Heart J 1994 ; 15 (Suppl B) : 14-19.
 
19) The Acute Infarction Ramipril Efficacy (AIRE) study investigators : Effects of ralnipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993 ; 542 : 821-828.
 
20) Kober L, Torp-Pedersen C, Carlsen JE, et al : A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfUnction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) study group. N Engl J Med 1995 ; 333 : 1670-1676.
 
21) Flather MD, Yusuf S, Kober L, et al : Long-term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction : A systematic overview of data from individual patients. Lancet 2000 ; 355 : 1575-1581.
PubMed
22) ACE Inhibitor Myocardial Infarction Collaborative Group : Indications for ACE inhibitors in the early treatment of acute myocardial infarction : Systematic overview of individual data from 100,000 patients in randomized trials. Circulation 1998 ; 97 : 2202-2212.
 
23) St John Lutton M, Pfeffer MA. Moye L, et al : Cardiovascular death and left ventricular remodeling two years after myocardial infarction. Baseline predictors and impact of captopril ; Information from the Survival and Ventricular Enlargement (SAVE) Trial. Circulation 1997 ; 96 : 3294-3299.
 
24) Dickstein K, Kjekshus J, Myhre ES, et al : Effects of losartan and captopril on mortality and morbidity in high risk patients after acute myocardial infarction : The OPTIMAAL randomized trial. Lancet 2002 ; 360 : 752-760.
 
25) Pfeffer MA, McMurray J, Leizorovicz A, et al : Valsaltan in acute myocardial infarction trial (VALLANT) : Rationale and design. Am Heart J 2000 ; 140 : 727-734.
 
26) Yusuf S, Peto R, Lewis J, et al : Beta blockade during and after myocardial infarction ; An overview of the randomized trials. Prog Cardiovasc Dis 1985 ; 27 : 335-371.
PubMed
27) ISIS-1 Collaborative Group : Randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction. Lancet 1986 : 57-66.
 
28) The TIMI Study Group : Comparison of invasive and conservative strategies after treatment with intravenous plasminogen activator in acute myocardial infarction : Results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. N Engl J Med 1989 ; 320 : 618-627.
 
29) The MIAMI trial research group : Metoprolol in acute myocardial infarction : A randomized placebocontrolled international trial. Eur Heart J 1985 ; 6 : 199-226.
 
30) Soriano JB, Hoes AW, Meems L, et al : Increased survival with beta-blockers : Importance of ancillary properties. Prog Cardiovasc Dis 1997 ; 34 : 445-456.
 
31) Freemantle N, Cleland J, Young P, et al : β blocker after myocardial infarction : Systematic review and meta regression analysis. Brit Med J 1999 ; 318 : 1730-1737.
 
32) Otterstad J, Ford I : The effect of carvedilol in patients with impaired left ventricular systolic hmction following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with beta-blocker trials? Eur J Heart Fail 2002 ; 4 : 501-506.
PubMed
33) Phillips KA, Shlipak MG, Coxson P, et al : Health and economic benefits of increased beta-blocker use following myocardial infarction. JAMA 2000 ; 284 : 2748-2754.
PubMed
34) Garg R, Gorlin R, Smith T : The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997 ; 336 : 525-533.
 
35) Packer M, Carver JR, Rodeheffer RJ, et al : Effect of milrinone on mortality in severe chronic heart failure ; The Prospective Randomized Milrinone Survival Evaluation (PROMISE). N Engl J Med 1991 ; 325 : 1468-1475.
PubMed
36) ISIS-2 (Second International Study of Infarct Survival) Collaborative Group : Randomized trial of intavenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction : ISIS-2. Lancet 1988 ; 2 : 349-360.
PubMed
37) Antiplatelet THalists' Collaboration : Collaborative overview of randomized trials of antiplatelet therapy-I : Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994 : 308 : 81-106.
 
38) Yasue H, Ogawa H, Tanaka H (et al) for the Japanese Antiplatelets Myocardial Infarction Study (JAMIS) Investigators : Effects of aspirin and trapidil on cardiovascular events after acute lnyocardial infarction. Am J Cardiol 1999 : 83 : 1308-1313.
PubMed
39) Quinn MJ, Fitzgerald DJ : Ticlopidine and clopidogrel. Circulation 1999 ; 100 : 1667-1672.
PubMed
40) Schomig A, Neumann FJ, Walter H, et al : Coronary stent placement in patients with acute myocardial infarction : Comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy. J Am Coll Cardiol 1997 ; 29 : 28-34.
 
41) Bertrand ME, Rupprecht HJ, Urban HJ, et al : Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : The Clopidogrel Aspirin Stent International Cooperative Study (CIASSICS). Circulation 2000 ; 102 : 624-629.
 
42) Yusuf S, Mehta SR, Zhao F, et al : Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation 2003 ; 107 : 966-972.
PubMed
43) Tsuchikane E, Fukuhara A, Kobayashi T, et al. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty. Circulation 1999 ; 100 : 21-26.
PubMed
44) Eisenberg MJ, Jamal S : Glycoprotein IIb/IIIa inhibition in the setting of acute ST-segment elevation myocardial infarction. J Am Coll Cardiol 2003 ; 42 : 1-6.
PubMed
45) Hirsh J : Heparin. N Engl J Med 1991 ; 324 : 1565-1574.
PubMed
46) Weitz JI : Low-molecular-weight heparin. N Engl J Med 1997 ; 337 : 688-698.
PubMed
47) ISIS-3 (Third International Study of Infarct Surviva1) Collaborative Group ; ISIS-3 : A randomized comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992 ; 339 : 753-770.
 
48) GISSI-2 : A fractional randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990 ; 336 : 65-71.
 
49) GISSI-2 (The International Study Group) : In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. Lancet 1990 ; 336 : 71-75.
PubMed
50) Collins R, MacMahon S, Flather M, et al : Clinical effects of anticoagulant therapy in suspected acute myocardial infarction : Systematic overview of randomized trials. BMJ 1996 ; 313 : 652-659.
PubMed
51) Hsia J, Hamilton WP, Kleiman N, et al : A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue-plasminogen activator for acute myocardial infarction. N Engl J Med 1990 ; 323 : 1433-1437.
PubMed
52) Narins CR, Hillegass WB, Nelson CL, et al : Relation between activated clotting time during angioplasty and abrupt closure. Circulation 1996 ; 93 : 667-671.
PubMed
53) Ross AM, Molhoek P, Lundergan C, et al : Randomized comparison of enoxaparin, a low-molecularweight heparin . with unfractionated heparin adjunctive to recombinant tissue plasminogen activator throbolysis and aspirin : Second trial of Heparin and Aspirin Reperfusion Therapy (HART II). Circulation 2001 ; 104 : 648-652.
 
54) The Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators : Efficacy and safety of tenecteplase in combination with enoxaparin, abxicimab, or unfractionated heparin : The ASSENT-3 randomized trial in acute myocardial infarction. Lancet 2001 ; 358 : 605-613.
PubMed
55) Wong GC, Giugliano RP, Antman EM : Use of low-molecular-weight heparin in the management of acute coronary artery syndromes and percutaneous coronary intervention. JAMA 2003 ; 289 : 331-342.
PubMed
56) Coumadin Aspirin Rinfarction Study Investigators : Randomized double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Lancet 1997 ; 350 : 389-396.
 
57) Hurlen M et al : Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 2002 ; 347 : 969-974.
 

第10章 退院・社会復帰

P.222 掲載の参考文献
1) The TIMI Research Group : Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction : TIMI IIA results. JAMA 1988 ; 260 : 2849-2858.
 
2) Topol EJ, Califf RM, George BS, et al : A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987 ; 317 : 581-588.
PubMed
3) Ross AM, Coyne KS, Reiner JS, et al : A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction : The PACT trial. J Am Coll CardioI 1999 ; 34 : 1954-1962.
 
4) DeBusk RF, Blomqvist CG, Kouchoukos NT, et al : Identification and treatment of low-risk patients after acute myocardial infarction and coronary-artery bypass graft surgery. N Engl J Med 1986 : 314 : 161-166.
PubMed
5) Keeley EC, Boura JA, Grines CL : Comparison of primary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review of 23 randomised trials. Lancet 2003 ; 361 : 13-20.
 
6) Weaver WD , Simes J, Betriu A, et al : Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative study. JAMA 1997 ; 278 : 2093-2098.
 
7) Bartholomew BA, Harjai KJ, Grines CL, et al : Variation in hospital length of stay in patients with acute myocardial infarction undergoing primary angioplasty and the need to change the diagnosticrelated group system. Am J Cardiol 2003 ; 92 : 830-833.
PubMed
8) National Heart Attack Alert Program (NHAAP) Coordinating Committee Critical Pathways Writing Group : Critical pathways for management of patients with acute coronary syndromes : An assessment by the National Heart Attack Alert Program. Am Heart J 2002 ; 143 : 777-789.
PubMed
9) Bogaty P, Dumont S, O'Hara GE, et al : Randomized trial of noninvasive strategy to reduce hospital stay with low-risk myocardial infarction. J Am Coll Cardiol 2001 ; 37 : 1289-1296.
PubMed
10) O'Connor GT, Burning GT, Yusuf S, et al : An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989 ; 80 : 234-244.
 
11) Fletcher GF, Balady GJ, Amsterdam EA, et al : Exercise standard for testing and training : A statement for healthcare professionals from the American Heart Association. Circulation 2001 ; 104 : 1694-1740.
PubMed
12) Oldridge NB, Guyatt GH, Fischer ME, et al : Cardiac rehabilitation after myocardial infarction : Combined experience of randomized clinical trials. JAMA 1988 ; 260 : 945-950.
PubMed
13) Dom J, Naughton J, Imamura D, et al : Results of a multicenter randomized clinical trial of exercise and long-term survival in myocardial infarction patients : The National Exercise and Heart Disease Project (NEHDP). Circulation 1999 ; 100 : 1764-1769.
 
14) Bodestam E. Breikss A, Hartford M : Effects of early rehabilitation on consumption of medical care during the first year after acute myocardial infarction in patients > or = 65 years of age. Am J Cardiol 1995 ; 75 : 767-771.
PubMed
15) Oldridge N, Furlong W, Feeny D, et al : Economic evaluation of cardiac rehabilitation soon after acute myocardial infarction. Am J Cardiol 1993 ; 72 : 154-161.
PubMed
16) Levin LA, Perk J, Hedback B : Cardiac rehabilitation ; acost analysis. J Intern Med 1991 ; 230 : 427-434.
 
17) Herzeanu HL, Shemiesh J, Aron IA, et al : Ventricular arrhythmias in rehabilitated and nonrehabilitated post myocardial infarction patients with left ventricular dysfunction. Am J Cardiol 1993 ; 71 : 24-27.
 
18) The Scandinavian Simvastatin Survival Study (4S) : Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease. Lancet 1994 ; 344 : 1383-1389.
 
19) Sacks FM, Pfeffer MA, Move LA et al, for the Cholesterol and Recurrent Events Trial Investigators : The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996 ; 335 : 1001-1009.
 
20) Ansell BJ, Watson KE, Fogelman KE, et al : An evidence-based assessment of t. he NCEP Adult Treatment Panel II guidelines : National Cholesterol Education Program. JAMA 1999 ; 282 : 2051-2057.
 
21) The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group : Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998 ; 339 : 1349-1357.
 
22) Libby P, Aikawa M : Stabilization of atherosclerotic plaques : New mechanisms and clinical targets. Nature Medicine 2002 ; 8 : 1257-1262.
PubMed
23) Sacks FM, et al : The effects of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996 ; 335 : 1001-1009.
 
24) Stenestrand U, Wallentin L, for the Swedish Register of Cardiac Intensive Care (RIKS-HIA) : Early statin treatment fbllowing acute myocardial infarction and 1-year survival. JAMA 2001 ; 285 : 430-436.
PubMed
25) Schwartz GG, Olson AG, Ezekowitz MD, et al : Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL Study : Randomized control study. JAMA 2001 ; 285 : 1711-1718.
 
26) Ridker PM, Rifai N, Pfeffer MA, et al : Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1999 ; 100 : 230-235.
 
27) Antiplatelet THalists'Collaboration : Collaborative overview of randomized trials of antiplatelet therapy : I. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994 ; 308 : 81-106.
PubMed
28) Coumadin aspirin rinfarction study investigators : Randomized double-blind trial of fixed low-dose warfarin with aspiHn after myocardial infarction. Lancet 1997 ; 350 : 389-396.
 
29) ISIS-4 : A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995 ; 345 : 669-685.
PubMed
30) The Multicenter Diltiazem Postinfarction Trial Research Group : The effec t of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988 ; 319 : 385-392.
 
31) Boden WE, et al : Diltiazem in acute myocardial infarction treated with thrombolytic agents : A randomized placebo-controlled trial. Imcomplete Infarction Trial of European Research Collaborators Evaluating Prognosis post-Thrombolysis (INTERCEPT). Lancet 2000 ; 35 : 1751-1756.
 
32) Pfeffer MA, Braunwald E, Moye LA, et al : Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction : Results of the survival and ventricular enlargement trial-the SAVE Investigators. N Engl J Med 1992 ; 327 : 669-677.
 
33) The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators : Effect of ramipril on mortality of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993 ; 342 : 821-828.
 
34) Gustafsson I, Torp-Pedersen C, Kober L, et al : Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction. J Am Coll Cardiol 1999 ; 34 : 83-89.
PubMed
35) Freemantle N, Cleland J, Young P, et al : β blockade after myocardial infarction : Systematic review and meta regression analysis. BMJ 1999 ; 318 : 730-737.
 
36) Pradhan AD, Mason JE, Rossouw JE, et al : Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease : Prospective analysis from the Women's Health Initiative observational study. JAMA 2002 ; 288 : 980-987.
 
37) Manson JE, Hsia J, Johnson KC, et al : Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003 ; 349 : 523-534.
PubMed

書評

最近チェックした商品履歴

Loading...